Impact of Food Combination on Starch Digestion and Gastric Processing
DECOUVRIR-M
Digestion: Building a Better Health and Better Understanding the Digestive Processes Thanks to Magnetic Resonance Imaging
1 other identifier
interventional
28
1 country
1
Brief Summary
The results of our in vitro studies strengthen the hypothesis that the contribution of salivary alpha-amylase to starch digestion has been underrated and that this enzyme can play an important role in this process. As a result, its inhibition could constitute an opportunity to reduce the glycemic response elicited by starch-rich foods. The main goal of this study is to verify whether inhibiting salivary alpha-amylase upon the consumption of starchy foods, can have an impact on the postprandial glycemic response, and/or satiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2017
CompletedFirst Posted
Study publicly available on registry
August 29, 2017
CompletedStudy Start
First participant enrolled
January 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 6, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 6, 2018
CompletedJune 7, 2019
June 1, 2019
6 months
August 25, 2017
June 5, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Energy intake (Main outcome of Part 1)
Consumption at an ad libitum meal served 3 h after each test-meal during part 1
3 hours
Gastric emptying (Main outcome of Part 2)
Gastric empting kinetics of each test-meal, evaluated by MRI, during part 2
3 hours
Secondary Outcomes (2)
Glycemic Response (Secondary outcome of Parts 1 and 2)
At baseline and and at different time-points during 3 hours after after consuming the test meal
Subjective appetite sensations (Secondary outcome of Part 2)
At baseline and at different time-points during 3 hours after consuming the test meal
Other Outcomes (3)
End of the day questionnaire
12-16 hours after the test meal (Part 1 and 2)
Gastric contractions
At baseline and during 3 hours after after consuming the test meal (Part 2 only)
Amylolytic activity of saliva
At baseline (Part 1)
Study Arms (6)
Part 1 - Bread + Water
OTHERParticipants in this arm will randomly consume bread and 250 mL of water on 1 out of 3 visits of Part 1.
Part 1 - Bread + Lemon Juice
OTHERParticipants in this arm will randomly consume bread and 250 mL of lemon juice on 1 out of 3 visits of Part 1.
Part 1 - Bread + Tea
OTHERParticipants in this arm will randomly consume bread and 250 mL of tea on 1 out of 3 visits of Part 1.
Part 2 - Bread + water
OTHERParticipants in this arm will randomly consume bread and 250 mL of water supplemented with 20 peas on 1 out of 3 visits of Part 2.
Part 2 - Bread+ Lemon Juice
OTHERParticipants in this arm will randomly consume bread and 250 mL of lemon juice supplemented with 20 peas on 1 out of 3 visits of Part 2.
Part 2 - Bread+ tea
OTHERParticipants in this arm will randomly consume bread and 250 mL of tea supplemented with 20 peas on 1 out of 3 visits of Part 2.
Interventions
Serving of wheat bread providing 50 g of carbohydrates
Eligibility Criteria
You may qualify if:
- To be overall healthy
- To be between 18 and 60 years old
- BMI between 18 and 25 (lean)
- No eating disorders
- No major weight changes (\> 3kg in previous 3 months)
- Structured eating habits (3 main meals/day, everyday)
- Not using corticoid drugs, or antidepressives known to influence food consumption, appetite and/or mood.
- Not using medication known to influence glucose tolerance: acetylsalicylic acid or thyroxin, vitamin or mineral-based dietary supplements, and drugs to control hypertension or osteoporosis are acceptable
- No allergies to the foods in the test-meals and ad libitum meal
- No abusive alcohol consumption
- No intensive exercising habits
- No participation in a clinical study within the previous 6 months
- To enjoy the foods in the test-meals and ad libitum meals
- To be affiliated to a social security system
- To be available to participate in study sessions
- +11 more criteria
You may not qualify if:
- Any contraindications to an MRI exam: claustrophobia, tatoos, presence of ferromagnetic elements, having a pacemaker, metallic prosthesis, cochlear implants, vascular clips, insulin pumps
- Any condition or disease that might affect the results of MRI exams.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre de Recherche sur Volontaires (CRV), Hospital Avicenne
Bobigny, Île-de-France Region, 93000, France
Related Publications (1)
Freitas D, Boue F, Benallaoua M, Airinei G, Benamouzig R, Lutton E, Jourdain L, Dubuisson RM, Maitre X, Darrasse L, Le Feunteun S. Glycemic response, satiety, gastric secretions and emptying after bread consumption with water, tea or lemon juice: a randomized crossover intervention using MRI. Eur J Nutr. 2022 Apr;61(3):1621-1636. doi: 10.1007/s00394-021-02762-2. Epub 2022 Jan 11.
PMID: 35013789DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Benamouzig, MD, PhD
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, MD, PhD
Study Record Dates
First Submitted
August 25, 2017
First Posted
August 29, 2017
Study Start
January 19, 2018
Primary Completion
July 6, 2018
Study Completion
July 6, 2018
Last Updated
June 7, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share